Panel Discussion: What are the Evidence Gaps Affecting Clinical Use of Next Generation Sequencing Tests in Oncology?

This panel discussion reviewed the evidence gaps affecting clinical use of next generation sequencing tests in oncology? Patricia Deverka was the moderator. Participants included Alberto Gutierrez, FDA, Elaine K. Jeter, Palmetto GBA, Robert Lechleider, United States Diagnostics Standards, Gary Lyman, Duke Cancer Institute, Sarah L. Zimmerman, Illumina, Inc.